
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.
Click the title above for a link to open the Pharmaceutical Executive November 2024 issue in an interactive PDF format.
about 2 years ago
AI’s Attention Spanabout 2 years ago
Noam Solomon: Bringing the Human Story to AIabout 2 years ago
ROI and Rare Disease: Retooling the ‘Gene’ Value Machineabout 2 years ago
The Leap Forward: Practical Gains for Pharma AI Useabout 2 years ago
Powering Pipelines Forward: Approach Science Differentlyabout 2 years ago
Navigating the Current Landscape for Pharma Leadersabout 2 years ago
Passage to Asia: Early Access for Innovative Therapiesabout 2 years ago
Digital Protection: Q&A with Jeffrey Bernstein





